natalizumab (Q386119)
Jump to navigation
Jump to search
pharmaceutical drug
- AN100226m
- PB006
- anti-alpha4 integrin
- anti-VLA4
- antegran
- natalizumab-sztn
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | natalizumab |
pharmaceutical drug |
|
Statements
1 reference
Natalizumab (English)
17 November 2015
1 reference
1 reference
natalizumab (English)
1 reference
Natalizumab (English)
19 January 2016
1 reference
2 October 2018
1 reference
2 October 2018
1 reference
2 October 2018
0 references
1 reference
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)
1 reference
Natalizumab (English)
17 November 2015
1 reference
1 reference
Natalizumab (English)
17 November 2015
Identifiers
1 reference
Natalizumab (English)
17 November 2015
1 reference
Natalizumab (English)
19 January 2016
1 reference
28 October 2019
Natalizumab (English)
10 May 2021
1 reference
Natalizumab (English)
17 November 2015
2 references
Natalizumab (English)
17 November 2015
1 reference
NATALIZUMAB (English)
19 January 2016
1 reference
NATALIZUMAB (English)
19 January 2016
1 reference
Sitelinks
Wikipedia(21 entries)
- arwiki ناتاليزوماب
- cswiki Natalizumab
- dewiki Natalizumab
- enwiki Natalizumab
- eswiki Natalizumab
- fawiki ناتالیزومب
- frwiki Natalizumab
- hewiki נטליזומאב
- itwiki Natalizumab
- jawiki ナタリズマブ
- nlwiki Natalizumab
- orwiki ନାଟାଲିଜୁମାବ
- plwiki Natalizumab
- ptwiki Natalizumab
- ruwiki Натализумаб
- shwiki Natalizumab
- srwiki Natalizumab
- svwiki Natalizumab
- trwiki Natalizumab
- ukwiki Наталізумаб
- viwiki Natalizumab